Jessie Kimbrough Marshall1, Olive M Mbah2, Jean G Ford3, Darcy Phelan-Emrick4, Saifuddin Ahmed5,6, Lee Bone7, Jennifer Wenzel2,8, Gary R Shapiro9, Mollie Howerton10, Lawrence Johnson11, Qiana Brown12, Altovise Ewing13, Craig Evan Pollack4,14. 1. Division of General Medicine, University of Michigan Health System, Ann Arbor, MI, USA. 2. Department of Oncology, Johns Hopkins School of Medicine, Baltimore, MD, USA. 3. Department of Medicine, The Brooklyn Hospital Center, Brooklyn, NY, USA. jgf9001@nyp.org. 4. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. 5. Department of Population, Family and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. 6. Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. 7. Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. 8. Department of Acute and Chronic Care, Johns Hopkins School of Nursing, Baltimore, MD, USA. 9. Health Partners Cancer Program and Institute for Education and Research, Minneapolis, MN, USA. 10. Centers for Medicare and Medicaid Services, Baltimore, MD, USA. 11. Park West Health Systems, Baltimore, MD, USA. 12. TVCOFA Corporation, Baltimore, MD, USA. 13. Formerly of the Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. 14. Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Abstract
BACKGROUND: There is growing evidence that patient navigation improves breast cancer screening rates; however, there are limited efficacy studies of its effect among African American older adult women. OBJECTIVE: To evaluate the effect of patient navigation on screening mammography among African American female Medicare beneficiaries in Baltimore, MD. DESIGN: The Cancer Prevention and Treatment Demonstration (CPTD), a multi-site study, was a randomized controlled trial conducted from April 2006 through December 2010. SETTING: Community-based and clinical setting. PARTICIPANTS: The CPTD Screening Trial enrolled 1905 community-dwelling African American female Medicare beneficiaries who were ≥65 years of age and resided in Baltimore, MD. Participants were recruited from health clinics, community centers, health fairs, mailings using Medicare rosters, and phone calls. INTERVENTIONS: Participants were randomized to either: printed educational materials on cancer screening (control group) or printed educational materials + patient navigation services designed to help participants overcome barriers to cancer screening (intervention group). MAIN MEASURE: Self-reported receipt of mammography screening within 2 years of the end of the study. KEY RESULTS: The median follow-up period for participants in this analysis was 17.8 months. In weighted multivariable logistic regression analyses, women in the intervention group had significantly higher odds of being up to date on mammography screening at the end of the follow-up period compared to women in the control group (odds ratio [OR] 2.26, 95 % confidence interval [CI]1.59-3.22). The effect of the intervention was stronger among women who were not up to date with mammography screening at enrollment (OR 3.63, 95 % CI 2.09-6.38). CONCLUSION:Patient navigation among urban African American Medicare beneficiaries increased self-reported mammography utilization. The results suggest that patient navigation for mammography screening should focus on women who are not up to date on their screening.
RCT Entities:
BACKGROUND: There is growing evidence that patient navigation improves breast cancer screening rates; however, there are limited efficacy studies of its effect among African American older adult women. OBJECTIVE: To evaluate the effect of patient navigation on screening mammography among African American female Medicare beneficiaries in Baltimore, MD. DESIGN: The Cancer Prevention and Treatment Demonstration (CPTD), a multi-site study, was a randomized controlled trial conducted from April 2006 through December 2010. SETTING: Community-based and clinical setting. PARTICIPANTS: The CPTD Screening Trial enrolled 1905 community-dwelling African American female Medicare beneficiaries who were ≥65 years of age and resided in Baltimore, MD. Participants were recruited from health clinics, community centers, health fairs, mailings using Medicare rosters, and phone calls. INTERVENTIONS:Participants were randomized to either: printed educational materials on cancer screening (control group) or printed educational materials + patient navigation services designed to help participants overcome barriers to cancer screening (intervention group). MAIN MEASURE: Self-reported receipt of mammography screening within 2 years of the end of the study. KEY RESULTS: The median follow-up period for participants in this analysis was 17.8 months. In weighted multivariable logistic regression analyses, women in the intervention group had significantly higher odds of being up to date on mammography screening at the end of the follow-up period compared to women in the control group (odds ratio [OR] 2.26, 95 % confidence interval [CI]1.59-3.22). The effect of the intervention was stronger among women who were not up to date with mammography screening at enrollment (OR 3.63, 95 % CI 2.09-6.38). CONCLUSION:Patient navigation among urban African American Medicare beneficiaries increased self-reported mammography utilization. The results suggest that patient navigation for mammography screening should focus on women who are not up to date on their screening.
Authors: Donald Musa; Richard Schulz; Roderick Harris; Myrna Silverman; Stephen B Thomas Journal: Am J Public Health Date: 2008-10-15 Impact factor: 9.308
Authors: Sam Harper; John Lynch; Stephen C Meersman; Nancy Breen; William W Davis; Marsha C Reichman Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-01 Impact factor: 4.254
Authors: Sarabeth Broder-Fingert; Sarah Qin; Julia Goupil; Jessica Rosenberg; Marilyn Augustyn; Nate Blum; Amanda Bennett; Carol Weitzman; James P Guevara; Ada Fenick; Michael Silverstein; Emily Feinberg Journal: Autism Date: 2018-11-08
Authors: Yamile Molina; Anne E Glassgow; Sage J Kim; Nerida M Berrios; Heather Pauls; Karriem S Watson; Julie S Darnell; Elizabeth A Calhoun Journal: Contemp Clin Trials Date: 2016-12-08 Impact factor: 2.226
Authors: Katia Noyes; John R T Monson; Irfan Rizvi; Ann Savastano; James S A Green; Nick Sevdalis Journal: J Oncol Pract Date: 2016-09-30 Impact factor: 3.840